| 2018 |
| 07/18 | 15:00 アルツハイマー治療貼付剤MRX-7MLL非臨床試験開始のお知らせ |
| 07/12 | 760 | 774 | 754 | 761 | +0.53% | 109,900 | 77億6303万 | -8.09% |
| 07/11 | 777 | 802 | 749 | 757 | -1.69% | 227,200 | 77億2223万 | -9.77% |
| 07/10 | 802 | 807 | 769 | 770 | -4.7% | 210,900 | 78億5484万 | -8.77% |
| 07/09 | 778 | 809 | 766 | 808 | +4.66% | 249,100 | 82億4248万 | -4.83% |
| 07/06 | 747 | 773 | 735 | 772 | +5.46% | 196,200 | 78億7524万 | -9.39% |
| 07/05 | 772 | 788 | 729 | 732 | -5.79% | 255,100 | 74億6720万 | -14.69% |
| 07/04 | 759 | 786 | 751 | 777 | +1.57% | 156,600 | 79億2625万 | -10.38% |
| 07/03 | 784 | 800 | 755 | 765 | -3.65% | 306,800 | 78億384万 | -12.27% |
| 07/02 | 15:00 第三者割当による第13回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ |
| 07/02 | 802 | 815 | 791 | 794 | -1.73% | 101,600 | 80億9967万 | -9.67% |
| 06/29 | 802 | 830 | 794 | 808 | +0.62% | 124,800 | 82億4248万 | -8.8% |
| 06/28 | 810 | 823 | 788 | 803 | -2.07% | 209,500 | 81億9148万 | -10.08% |
| 06/27 | 801 | 821 | 795 | 820 | +1.23% | 147,100 | 83億6490万 | -9.09% |
| 06/26 | 775 | 811 | 767 | 810 | +3.98% | 301,100 | 82億6289万 | -11.09% |
| 06/25 | 830 | 845 | 774 | 779 | -5.8% | 371,700 | 79億4665万 | -15.42% |
| 06/22 | 843 | 850 | 820 | 827 | -4.06% | 145,900 | 84億3630万 | -11.27% |
| 06/21 | 870 | 888 | 850 | 862 | 0% | 151,900 | 87億3326万 | -8.59% |
| 06/20 | 825 | 868 | 800 | 862 | +3.23% | 313,500 | 87億3326万 | -9.36% |
| 06/19 | 876 | 881 | 814 | 835 | -5.11% | 429,300 | 84億5971万 | -12.84% |
| 06/18 | 904 | 904 | 857 | 880 | -3.19% | 327,300 | 89億1563万 | -9% |
| 06/15 | 902 | 923 | 902 | 909 | +0.11% | 120,300 | 92億944万 | -6.67% |
| 06/14 | 906 | 920 | 904 | 908 | -0.44% | 107,100 | 91億9931万 | -7.35% |
| 06/13 | 920 | 921 | 901 | 912 | -0.98% | 194,900 | 92億3983万 | -7.69% |
| 06/12 | 906 | 921 | 898 | 921 | +1.66% | 240,600 | 93億3101万 | -7.53% |
| 06/11 | 924 | 942 | 906 | 906 | -2.79% | 340,600 | 91億7904万 | -9.85% |
| 06/08 | 1,033 | 1,035 | 928 | 932 | -9.78% | 2,125,200 | 94億4246万 | -8.09% |
| 06/07 | 1,000 | 1,033 | 977 | 1,033 | +16.99% | 602,900 | 104億6573万 | +1.08% |
| 06/06 | 15:00 MRX-5LBTの生物学的同等性を示す検証的臨床試験結果のお知らせ |
| 06/06 | 879 | 899 | 863 | 883 | +0.46% | 167,000 | 89億4602万 | -13.85% |
| 06/05 | 885 | 896 | 860 | 879 | -2.33% | 335,400 | 89億550万 | -15.07% |
| 06/04 | 926 | 928 | 885 | 900 | -2.6% | 254,900 | 91億1826万 | -14.04% |
| 06/01 | 15:00 第三者割当による第13回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ |
| 06/01 | 927 | 952 | 917 | 924 | -1.7% | 122,500 | 93億6141万 | -12.67% |
| 05/31 | 926 | 941 | 922 | 940 | +2.4% | 95,900 | 95億2351万 | -11.82% |
| 05/30 | 900 | 941 | 897 | 918 | -0.33% | 269,700 | 93億62万 | -14.6% |
| 05/29 | 975 | 981 | 910 | 921 | -6.02% | 496,700 | 93億3101万 | -15.12% |
| 05/28 | 983 | 1,013 | 977 | 980 | -0.2% | 245,200 | 99億2877万 | -10.42% |
| 05/25 | 1,020 | 1,026 | 975 | 982 | -4.1% | 498,300 | 99億4903万 | -10.89% |
| 05/24 | 1,052 | 1,060 | 1,017 | 1,024 | -2.94% | 357,300 | 103億7455万 | -7.66% |
| 05/23 | 1,061 | 1,090 | 1,051 | 1,055 | -0.28% | 184,400 | 106億8862万 | -5.38% |
| 05/22 | 1,053 | 1,079 | 1,034 | 1,058 | 0% | 259,800 | 107億1902万 | -5.79% |
| 05/21 | 1,065 | 1,079 | 1,052 | 1,058 | -2.4% | 230,500 | 106億4496万 | -6.54% |
| 05/18 | 1,073 | 1,117 | 1,059 | 1,084 | +0.28% | 334,400 | 109億655万 | -5% |
| 05/17 | 1,041 | 1,086 | 1,041 | 1,081 | +4.14% | 132,700 | 108億7637万 | -7.21% |
| 05/16 | 1,028 | 1,043 | 1,020 | 1,038 | -1.52% | 394,600 | 104億4373万 | -12.92% |
| 05/15 | 1,068 | 1,068 | 1,042 | 1,054 | -0.75% | 182,500 | 106億471万 | -13.61% |
| 05/14 | 1,073 | 1,105 | 1,055 | 1,062 | +1.53% | 409,900 | 106億8520万 | -14.84% |
| 05/11 | 15:00 平成30年12月期第1四半期決算短信〔日本基準〕(連結) |
| 05/11 | 1,092 | 1,098 | 1,029 | 1,046 | -5.51% | 599,000 | 105億2422万 | -17.96% |
| 05/10 | 1,095 | 1,122 | 1,079 | 1,107 | +0.36% | 385,500 | 111億3796万 | -15.43% |
| 05/09 | 1,145 | 1,149 | 1,102 | 1,103 | -3.67% | 396,400 | 110億9772万 | -17.81% |
| 05/08 | 1,138 | 1,155 | 1,127 | 1,145 | +1.24% | 331,500 | 115億2030万 | -16.61% |
| 05/07 | 15:00 マイクロニードル国際学会での発表に関するお知らせ |
| 05/07 | 1,105 | 1,140 | 1,100 | 1,131 | -0.62% | 286,600 | 113億7944万 | -19.5% |
| 05/02 | 1,094 | 1,145 | 1,091 | 1,138 | +2.52% | 231,000 | 114億4987万 | -20.86% |
| 05/01 | 1,130 | 1,144 | 1,090 | 1,110 | -2.72% | 525,200 | 111億6815万 | -24.34% |
| 04/27 | 12:00 第三者割当による第13回新株予約権(行使価額修正条項付)の発行価額の払込完了に関するお知らせ |
| 04/27 | 1,166 | 1,199 | 1,127 | 1,141 | -3.88% | 481,300 | 114億8005万 | -23.88% |
| 04/26 | 1,168 | 1,206 | 1,147 | 1,187 | +1.45% | 739,700 | 119億4288万 | -22.52% |
| 04/25 | 15:00 第12回新株予約権の取得及び消却完了に関するお知らせ |
| 04/25 | 1,130 | 1,185 | 1,116 | 1,170 | +4.19% | 453,400 | 117億7183万 | -25.24% |
| 04/24 | 1,158 | 1,169 | 1,117 | 1,123 | -2.43% | 459,200 | 112億9895万 | -29.68% |
| 04/23 | 1,139 | 1,176 | 1,133 | 1,151 | -1.54% | 269,400 | 115億8067万 | -29.3% |
| 04/20 | 1,128 | 1,196 | 1,122 | 1,169 | +0.95% | 382,500 | 111億7528万 | -29.62% |
| 04/19 | 1,141 | 1,168 | 1,111 | 1,158 | -0.43% | 553,900 | 110億7013万 | -31.72% |
| 04/18 | 1,169 | 1,194 | 1,135 | 1,163 | -1.11% | 388,600 | 111億1793万 | -32.89% |
| 04/17 | 1,181 | 1,197 | 1,124 | 1,176 | +0.43% | 952,600 | 112億4220万 | -33.26% |
| 04/16 | 1,257 | 1,269 | 1,164 | 1,171 | -5.64% | 807,200 | 111億9440万 | -34.54% |
| 04/13 | 1,255 | 1,264 | 1,200 | 1,241 | -3.12% | 1,072,500 | 118億6358万 | -31.78% |
| 04/12 | 12:00 マイクロニードルアレイ事業についての補足説明 |
| 04/12 | 1,311 | 1,359 | 1,254 | 1,281 | -1.31% | 1,076,200 | 122億4597万 | -30.42% |
| 04/11 | 15:00 第11回新株予約権の行使完了に関するお知らせ |
| 04/11 | 1,500 | 1,506 | 1,288 | 1,298 | -23.1% | 3,053,900 | 124億849万 | -30.25% |
| 04/10 | 15:00 第11回及び第12回新株予約権の取得及び消却に関するお知らせ |
| 04/10 | 15:00 第三者割当による第13回新株予約権(行使価額修正条項付)の発行及び第三者割当契約の締結に関するお知らせ |
| 04/10 | 1,731 | 1,744 | 1,680 | 1,688 | -3.21% | 417,900 | 161億3677万 | -10.12% |
| 04/09 | 1,718 | 1,775 | 1,700 | 1,744 | -0.23% | 179,600 | 166億7211万 | -7.09% |
| 04/06 | 1,723 | 1,771 | 1,680 | 1,748 | +1.45% | 369,700 | 167億1035万 | -7.07% |
| 04/05 | 1,798 | 1,816 | 1,709 | 1,723 | -2.27% | 503,100 | 164億7136万 | -8.35% |
| 04/04 | 1,906 | 1,910 | 1,750 | 1,763 | -7.5% | 959,400 | 168億5375万 | -5.67% |
| 04/03 | 1,890 | 1,921 | 1,863 | 1,906 | -0.52% | 353,500 | 182億2078万 | +2.86% |
| 04/02 | 1,900 | 1,980 | 1,887 | 1,916 | +1.22% | 415,700 | 183億1638万 | +4.41% |
| 03/30 | 1,932 | 1,944 | 1,859 | 1,893 | -2.02% | 397,100 | 180億9651万 | +4.41% |
| 03/29 | 1,951 | 1,981 | 1,900 | 1,932 | -1.23% | 433,200 | 184億6934万 | +7.81% |
| 03/28 | 1,892 | 1,992 | 1,880 | 1,956 | +4.26% | 548,300 | 186億9877万 | +10.38% |
| 03/27 | 1,947 | 2,004 | 1,857 | 1,876 | -1% | 630,700 | 179億3399万 | +7.02% |
| 03/26 | 1,944 | 1,960 | 1,838 | 1,895 | -4.29% | 714,400 | 181億1563万 | +9.03% |
| 03/23 | 15:00 CPN-101(MRX-4TZT)の開発・販売ライセンス契約先変更に関するお知らせ |
| 03/23 | 15:00 助成金受領に伴う特別利益の計上に関するお知らせ |
| 03/23 | 1,940 | 2,057 | 1,921 | 1,980 | -1% | 641,400 | 189億2820万 | +15.05% |
| 03/22 | 1,941 | 2,033 | 1,928 | 2,000 | +0.96% | 638,900 | 177億7940万 | +17.58% |
| 03/20 | 1,879 | 2,009 | 1,830 | 1,981 | +4.37% | 658,200 | 176億1049万 | +17.99% |
| 03/19 | 1,946 | 1,974 | 1,824 | 1,898 | -3.9% | 677,800 | 168億7265万 | +14.41% |
| 03/16 | 2,035 | 2,035 | 1,916 | 1,975 | -3.66% | 957,300 | 175億5715万 | +19.77% |
| 03/15 | 2,058 | 2,139 | 2,012 | 2,050 | -0.49% | 1,410,600 | 182億2388万 | +25.38% |
| 03/14 | 1,875 | 2,129 | 1,869 | 2,060 | +7.85% | 2,369,100 | 183億1278万 | +27.71% |
| 03/13 | 1,905 | 1,990 | 1,868 | 1,910 | +3.92% | 2,524,600 | 169億7932万 | +20.05% |
| 03/12 | 15:00 酸補足剤を含有する貼付製剤に関する特許(米国)査定のお知らせ |
| 03/12 | 1,900 | 1,926 | 1,799 | 1,838 | -4.22% | 1,676,800 | 163億3926万 | +16.11% |
| 03/09 | 1,810 | 1,978 | 1,770 | 1,919 | +6.91% | 1,942,500 | 170億5933万 | +21.92% |
| 03/08 | 1,805 | 1,815 | 1,743 | 1,795 | +0.96% | 884,800 | 159億5701万 | +15.88% |
| 03/07 | 1,716 | 1,824 | 1,682 | 1,778 | +3.13% | 1,730,800 | 158億588万 | +16.29% |
| 03/06 | 1,698 | 1,815 | 1,690 | 1,724 | +3.98% | 1,799,800 | 153億2584万 | +14.1% |
| 03/05 | 1,830 | 1,912 | 1,643 | 1,658 | -10.09% | 2,603,900 | 147億3912万 | +11.05% |
| 03/02 | 1,687 | 1,848 | 1,620 | 1,844 | +6.04% | 3,605,600 | 163億9260万 | +24.68% |
| 03/01 | 1,739 | 1,739 | 1,639 | 1,739 | +20.85% | 4,032,200 | 154億5918万 | +19.27% |
| 02/28 | 15:00 薬剤と有機溶媒と親油性膏体基剤と粉体を配合した貼付製剤組成物に関する特許(日本)査定のお知らせ |
| 02/28 | 15:00 当社独自の経皮吸収技術NCTS(R)を用いた第一三共との共同開発に関するお知らせ |
| 02/28 | 1,370 | 1,455 | 1,369 | 1,439 | +5.11% | 438,300 | 127億9227万 | -0.28% |
| 02/27 | 1,430 | 1,435 | 1,366 | 1,369 | -4.8% | 369,900 | 121億6999万 | -4.8% |
| 02/26 | 1,399 | 1,463 | 1,387 | 1,438 | +4.96% | 392,700 | 127億8338万 | +0.14% |
| 02/23 | 1,384 | 1,407 | 1,351 | 1,370 | -0.51% | 352,300 | 121億7888万 | -4.13% |
| 02/22 | 1,405 | 1,413 | 1,357 | 1,377 | -3.64% | 441,000 | 122億4111万 | -3.37% |
| 02/21 | 1,460 | 1,465 | 1,397 | 1,429 | -2.86% | 601,400 | 127億338万 | +0.63% |
| 02/20 | 1,505 | 1,539 | 1,464 | 1,471 | -2.65% | 339,200 | 130億7674万 | +4.18% |
| 02/19 | 1,484 | 1,532 | 1,449 | 1,511 | +2.65% | 533,700 | 134億3233万 | +7.54% |
| 02/16 | 17:45 (訂正)「主要株主の異動に関するお知らせ」の訂正について |
| 02/15 | 12:00 マイクロニードル及びマイクロニードルアレイに関する特許(米国)査定のお知らせ |
